Hexarelin: A Laboratory Research Reference

Hexarelin is a synthetic hexapeptide in the growth hormone-releasing peptide (GHRP) family. It is studied in laboratory research for its activity at the ghrelin/growth hormone secretagogue receptor and for its reported interactions with cardiac tissue in experimental models.

This page is a non-promotional scientific reference for researchers. It summarises the chemical identity, molecular characteristics, mechanism as described in the literature, research areas, and analytical testing of hexarelin. It does not provide dosing, therapeutic, or human-use guidance of any kind. Hexarelin supplied by Bulk Aussie Peptides is for laboratory research purposes only.

What Is Hexarelin?

Hexarelin is a synthetic, metabolically stabilised hexapeptide analogue in the growth hormone-releasing peptide class. It was developed from earlier GHRP compounds by incorporating non-proteinogenic and D-amino-acid residues to improve resistance to enzymatic degradation while retaining receptor activity. Its short sequence and synthetic nature make it a convenient reference tool for interrogating the growth hormone secretagogue receptor.

For background on how synthetic research peptides are produced and verified, see the synthetic peptides research guide.

Molecular Characteristics

Several molecular properties are used to identify hexarelin in analytical documentation:

• Classification: a synthetic growth hormone-releasing peptide (GHRP), a member of the growth hormone secretagogue receptor agonist family.
• Sequence: a six-amino-acid peptide typically written His-D-2Me-Trp-Ala-Trp-D-Phe-Lys-NH₂; the sequence incorporates D-amino acids and a 2-methyl-tryptophan residue.
• Molecular weight: reported in Daltons (Da) on product documentation; the measured value on a Certificate of Analysis should be compared against the theoretical mass derived from the sequence.
• Physical form: supplied as a lyophilised (freeze-dried) powder, the standard presentation for research peptides.

How Hexarelin Works

Hexarelin acts as an agonist at the growth hormone secretagogue receptor (GHS-R), the molecular target through which ghrelin exerts its activity. In laboratory models, engagement of this receptor is associated with growth hormone release via a signalling pathway that is distinct from that of GHRH, and which appears to depend on endogenous GHRH for its full effect.

A distinct line of investigation concerns hexarelin’s reported interaction with cardiac tissue, where it has been studied for binding and activity that appear to be mediated through the CD36 scavenger receptor in experimental preparations. These observations are preclinical and do not constitute a therapeutic use.

Areas of Scientific Research

The research literature describes several lines of investigation involving hexarelin:

• Growth hormone secretagogue receptor pharmacology: characterisation of receptor binding and signal transduction.
• Cardiac research: studies of hexarelin binding and activity in heart tissue, including the role of the CD36 receptor.
• Analogue comparison: work comparing hexarelin with related GHRP and ghrelin-derived peptides to understand structure–activity relationships.

These investigations are conducted in vitro or in approved animal research models under institutional oversight. They do not translate to approved human use.

Analytical Testing

As with other research peptides, hexarelin is characterised using:

• HPLC for purity assessment, reported as a percentage of total peak area.
• Mass spectrometry for identity confirmation, by comparing measured molecular mass to the theoretical value.

Guidance on interpreting the resulting documents is available in the article on how to read a peptide Certificate of Analysis.

Storage and Handling

In a laboratory context, lyophilised hexarelin is typically stored in a freezer, protected from light and moisture, and handled according to the product-specific documentation. Once reconstituted, the resulting solution is refrigerated and used within the timeframe stated in the documentation. General guidance is covered in the peptide storage and stability reference.

Frequently Asked Questions

• What is hexarelin? Hexarelin is a synthetic six-amino-acid growth hormone-releasing peptide (GHRP).
• What receptor does hexarelin target? It acts as an agonist at the growth hormone secretagogue receptor (GHS-R).
• Is hexarelin a ghrelin mimetic? It acts at the same receptor as ghrelin and is often classed among ghrelin-derived secretagogues for research purposes.
• What is hexarelin studied for? It is investigated in laboratory models for GHS-R pharmacology and for reported interactions with cardiac tissue.
• How is hexarelin purity tested? Purity is commonly estimated by HPLC, while identity is confirmed by mass spectrometry.

References

• Bodart, V., Bouchard, J.-F., McNicoll, N., Escher, E., Carriere, P., Ghigo, E., et al. (1999). Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. Circulation Research, 85(9), 796–802. PubMed 10532947
• Torsello, A., Luoni, M., Schweiger, F., Grilli, R., Guidi, M., Bresciani, E., et al. (1998). Novel hexarelin analogs stimulate feeding in the rat through a mechanism independent from the subtype-selective activation of the growth hormone secretagogue receptor. European Journal of Endocrinology, 138(2), 198–205. PubMed 9506867

Related Research Resources

• GHRP-6: A Laboratory Research Reference — a related growth hormone-releasing peptide.
• Ipamorelin: A Laboratory Research Reference — another secretagogue peptide.
• Synthetic Peptides: Research Guide — how research peptides are produced and verified.